These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19622904)
1. Emerging pharmacologic therapies for wet age-related macular degeneration. Ni Z; Hui P Ophthalmologica; 2009; 223(6):401-10. PubMed ID: 19622904 [TBL] [Abstract][Full Text] [Related]
2. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Ferrara N; Damico L; Shams N; Lowman H; Kim R Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284 [TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Noël A; Jost M; Lambert V; Lecomte J; Rakic JM Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433 [TBL] [Abstract][Full Text] [Related]
4. [Intravitreal anti-VEGF injections improve the visual prognosis of wet age related macular degeneration]. Ambresin A; Mantel I Rev Med Suisse; 2007 Jan; 3(94):137-41. PubMed ID: 17354539 [TBL] [Abstract][Full Text] [Related]
5. Emerging therapies for the treatment of neovascular age related macular degeneration. Yuan A; Kaiser PK Semin Ophthalmol; 2011 May; 26(3):149-55. PubMed ID: 21609228 [TBL] [Abstract][Full Text] [Related]
6. Emerging therapies for the treatment of wet age-related macular degeneration--VEGF Trap-Eye. Rejdak R; Szkaradek M; Grieb P; Jünemann AG Klin Oczna; 2011; 113(10-12):376-8. PubMed ID: 22384659 [TBL] [Abstract][Full Text] [Related]
13. Status of therapies in development for the treatment of age-related macular degeneration. Hunt DW; Margaron P IDrugs; 2003 May; 6(5):464-9. PubMed ID: 12789601 [TBL] [Abstract][Full Text] [Related]
14. Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline. Kaiser PK Ophthalmology; 2013 May; 120(5 Suppl):S11-5. PubMed ID: 23642781 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Treatment of Wet Type Age-related Macular Degeneration; Current and Evolving Therapies. Shams Najafabadi H; Daftarian N; Ahmadieh H; Soheili ZS Arch Iran Med; 2017 Aug; 20(8):525-537. PubMed ID: 28846017 [TBL] [Abstract][Full Text] [Related]
16. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292 [TBL] [Abstract][Full Text] [Related]